Literature DB >> 28252344

Autophagy-inducing natural compounds: a treasure resource for developing therapeutics against tissue fibrosis.

Xiao-Xi Lv1, Shan-Shan Liu1, Zhuo-Wei Hu1.   

Abstract

Tissue fibrosis is a common pathologic change of many chronic diseases, which is characterized by extracellular matrix accumulation in tissues and dysfunction of the injured organs. Despite there recently gain mechanistic insight into the pathogenesis of tissue fibrosis, therapeutics for tissue fibrosis and thus many chronic diseases remain a significant clinical unmet need. Recent progressions indicate that autophagy, a conserved lysosomal degradation process in eukaryotic cells, not only plays an important regulatory role in maintaining cellular and tissue homeostasis, but also contributes to the development and progression of tissue fibrosis in a diversity of organs. Interestingly, a number of natural compounds derived from plant or Chinese Herb Medicines (CHM), have been identified as modulators of autophagy, and may function as potential therapeutic agents for the treatment of different fibrotic diseases. In this review, we focus on several plant natural compounds that have well-known anti-fibrotic effects through regulating autophagic signal pathways or autophagy activity. These findings should provide important therapeutic clues and strategy for the development of new anti-fibrosis drugs.

Entities:  

Keywords:  Autophagic flux; Chinese Herb Medicines; autophagosome; fibroblast

Mesh:

Year:  2017        PMID: 28252344     DOI: 10.1080/10286020.2017.1279151

Source DB:  PubMed          Journal:  J Asian Nat Prod Res        ISSN: 1028-6020            Impact factor:   1.569


  4 in total

Review 1.  MicroRNA-34a: A Novel Therapeutic Target in Fibrosis.

Authors:  Min Zhao; Qin Qi; Shimin Liu; Rong Huang; Jiacheng Shen; Yi Zhu; Jing Chai; Handan Zheng; Huangan Wu; Huirong Liu
Journal:  Front Physiol       Date:  2022-06-20       Impact factor: 4.755

2.  Autophagy and its link to type II diabetes mellitus.

Authors:  Jai-Sing Yang; Chi-Cheng Lu; Sheng-Chu Kuo; Yuan-Man Hsu; Shih-Chang Tsai; Shih-Yin Chen; Yng-Tay Chen; Ying-Ju Lin; Yu-Chuen Huang; Chao-Jung Chen; Wei-De Lin; Wen-Lin Liao; Wei-Yong Lin; Yu-Huei Liu; Jinn-Chyuan Sheu; Fuu-Jen Tsai
Journal:  Biomedicine (Taipei)       Date:  2017-06-14

3.  Cardioprotective Effects of Taurisolo® in Cardiomyoblast H9c2 Cells under High-Glucose and Trimethylamine N-Oxide Treatment via De Novo Sphingolipid Synthesis.

Authors:  Stefania Lama; Vincenzo Monda; Maria Rosaria Rizzo; Marco Dacrema; Maria Maisto; Giuseppe Annunziata; Gian Carlo Tenore; Ettore Novellino; Paola Stiuso
Journal:  Oxid Med Cell Longev       Date:  2020-11-12       Impact factor: 6.543

Review 4.  Calorie Restriction for Cancer Prevention and Therapy: Mechanisms, Expectations, and Efficacy.

Authors:  Chiara Vidoni; Alessandra Ferraresi; Andrea Esposito; Chinmay Maheshwari; Danny N Dhanasekaran; Vincenzo Mollace; Ciro Isidoro
Journal:  J Cancer Prev       Date:  2021-12-30
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.